Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
(Image credit: Bloomberg/Getty Images)
from News : NPR https://ift.tt/3w6hIpT
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
(Image credit: Bloomberg/Getty Images)
No comments:
Post a Comment